These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19090592)

  • 1. Quality control in urodynamics: Analysis of an international multi-center study.
    Renganathan A; Cartwright R; Cardozo L; Robinson D; Srikrishna S
    Neurourol Urodyn; 2009; 28(5):380-4. PubMed ID: 19090592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrater reliability of filling cystometrogram interpretation in a multicenter study.
    Zimmern P; Nager CW; Albo M; Fitzgerald MP; McDermott S;
    J Urol; 2006 Jun; 175(6):2174-7. PubMed ID: 16697832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of urodynamic parameters in patients with overactive bladder.
    Frenkl TL; Railkar R; Palcza J; Scott BB; Alon A; Green S; Schaefer W
    Neurourol Urodyn; 2011 Nov; 30(8):1565-9. PubMed ID: 21674594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and agreement of urodynamics interpretations in a female pelvic medicine center.
    Whiteside JL; Hijaz A; Imrey PB; Barber MD; Paraiso MF; Rackley RR; Vasavada SP; Walters MD; Daneshgari F
    Obstet Gynecol; 2006 Aug; 108(2):315-23. PubMed ID: 16880301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of neurogenic bladder patients in The Netherlands: do urologists follow guidelines?
    Rikken B; Blok BF
    Neurourol Urodyn; 2008; 27(8):758-62. PubMed ID: 18508332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humpty-Dumpty--still alive. Quality control in urodynamics: analysis of an international multi-center study. Arasee Renganathan, Rufus Cartwright, Linda Cardozo, Dudley Robinson, and Sushma Srikrishna: Neurourology and urodynamics 28:380-384 (2009).
    Schaefer W
    Neurourol Urodyn; 2010 Jun; 29(5):797-8; author reply 799. PubMed ID: 19802877
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.
    Sahai A; Khan MS; Le Gall N; Dasgupta P;
    Urology; 2008 Mar; 71(3):455-9. PubMed ID: 18342186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is low bladder compliance predictive of detrusor overactivity?
    Harding C; Dorkin TJ; Thorpe AC
    Neurourol Urodyn; 2009; 28(1):74-7. PubMed ID: 18726946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of indicators assessing the quality of drug prescribing for asthma.
    Veninga CC; Denig P; Pont LG; Haaijer-Ruskamp FM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):143-61. PubMed ID: 11324741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the patient's position influence the detection of detrusor overactivity?
    Al-Hayek S; Belal M; Abrams P
    Neurourol Urodyn; 2008; 27(4):279-86. PubMed ID: 17724734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference urodynamic values for stress incontinent women.
    Nager CW; Albo ME; Fitzgerald MP; McDermott S; Wruck L; Kraus S; Howden N; Norton P; Sirls L; Varner E; Zimmern P;
    Neurourol Urodyn; 2007; 26(3):333-40. PubMed ID: 17315221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
    Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
    Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations relating to urinary sensation during detrusor overactivity.
    Lowenstein L; Pham T; Abbasy S; Kenton K; Brubaker L; Mueller ER; Shott S; Vardi Y; Gruenwald I; FitzGerald MP
    Neurourol Urodyn; 2009; 28(6):497-500. PubMed ID: 19090593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies.
    Smidt N; Rutjes AW; van der Windt DA; Ostelo RW; Bossuyt PM; Reitsma JB; Bouter LM; de Vet HC
    BMC Med Res Methodol; 2006 Mar; 6():12. PubMed ID: 16539705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traces: making sense of urodynamics testing--Part 9: Evaluation of sensations detrusor response to bladder filling.
    Gray M
    Urol Nurs; 2012; 32(1):21-8, 18. PubMed ID: 22474862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.